Ausgabe 5/2016
Inhalt (11 Artikel)
Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas
Matthias K. Auer, Günter K. Stalla, Mareike R. Stieg
Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up
Sammie Roberts, Manuel Thomas Borges, Kevin O. Lillehei, B. K. Kleinschmidt-DeMasters
Carotid artery protrusion and dehiscence in patients with acromegaly
Yasuo Sasagawa, Osamu Tachibana, Mariko Doai, Yasuhiko Hayashi, Hisao Tonami, Hideaki Iizuka, Mitsutoshi Nakada
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome
Mattia Barbot, Laura Trementino, Marialuisa Zilio, Filippo Ceccato, Nora Albiger, Andrea Daniele, Anna Chiara Frigo, Rodica Mardari, Giuseppe Rolma, Marco Boscaro, Giorgio Arnaldi, Carla Scaroni
Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome
G. Aranda, M. Careaga, F. A. Hanzu, I. Patrascioiu, P. Ríos, M. Mora, B. Morales-Romero, W. Jiménez, I. Halperin, G. Casals
Enhanced cosyntropin stimulation test performance enabled by electronic medical record
Anat Ben-Shlomo, Joseph Guzman, James Mirocha
Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening
Ruth Mangupli, Liliya Rostomyan, Emilie Castermans, Jean-Hubert Caberg, Paul Camperos, Jaime Krivoy, Elvia Cuauro, Vincent Bours, Adrian F. Daly, Albert Beckers
Geographic variation in cost of care for pituitary tumor surgery
Charles C. Lee, Kristopher T. Kimmell, Amy Lalonde, Peter Salzman, Matthew C. Miller, Laura M. Calvi, Ekaterina Manuylova, Ismat Shafiq, G. Edward Vates
Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis
Chiara Robba, Susanna Bacigaluppi, Nicola Bragazzi, Andrea Lavinio, Mark Gurnell, Federico Bilotta, David K. Menon
Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
Julie M. Silverstein
Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
Simon J. B. Aylwin, Istvan Bodi, Ronald Beaney